External validation study of Re-SCORTEN in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis

Affiliations

• ¹ Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA.
• ² Utrecht University Medical School, Utrecht, The Netherlands.
• ³ David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
• ⁴ Harvard Medical School, Boston, MA, USA.
• ⁵ University of Massachusetts Chan Medical School, Worcester, MA, USA.
• ⁶ Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.